Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, November 20, 2018
Eurofins has announced the company will distribute Synthego's synthetic single guide RNA (sgRNA) to their global customer database across 44 countries.
read more
Eurofins Scientific has signed an outsourcing agreement with Astellas to outsource one of its internal testing laboratories Astellas Analytical Science Laboratories.
read more
Eurofins Scientific has signed an exclusive agreement with Ekkio Capital to acquire the Amatsigroup for a price of approximately EUR 130m plus some residual debt at closing.
read more
Wednesday, February 24, 2021
Eurofins Scientific has announced the acquisition of Beacon Discovery, a drug discovery and CRO focused on GPCR research.
read more
Thursday, November 16, 2023
Eurofins, a prominent provider of testing services for food, environment, pharmaceuticals, cosmetics, and various research disciplines such as discovery pharmacology, forensics, advanced material sciences, and agroscience contract research, has ...
read more
Friday, September 23, 2016
• On the back of the strong performance of most of the Group’s businesses in H1 2016, and organic growth remaining above the Group’s 5% objective in July and August, Eurofins is raising its adjusted EBITDA objective for the full year 2016 from EUR ...
read more
Eurofins Pharma Bioanalytical Services announced it will extend its laboratory services to provide consulting to clients to who require expertise and experience in conducting large molecule preclinical and clinical studies.
read more
Tuesday, September 17, 2024
Eurofins Scientific announced the closing of its acquisition of Infinity Laboratories, Inc. Founded in 1991, Infinity operates eight state-of-the-art laboratories across the United States and employs approximately 100 staff.
read more
Eurofins Technologies announces the launch of its GSD NovaType III SARS-CoV-2 RT-PCR assay, developed for the rapid detection of SARS-CoV-2 Variants of Concern including B.1.617 (“India”), B.1.427/B.1.429 (“California/USA”), B.1.351 (“South Africa”) ...
read more
Eurofins Lancaster Laboratories, part of Eurofins Scientific has announced strategic plans for the expansion of its Dungarvan, Ireland campus, including development of a new building as well as expansion of its current facility.
read more
Eurofins Genomics has announced the U.S. commercial launch of a unique DNA synthesis service based on the company's revolutionary next-generation synthesis platform. The service, which is designed to supply small quantities of high-quality oligos for...
read more
Eurofins Scientific has announced the opening of its new state-of-the-art manufacturing and services facility in Louisville, KY, in the US. The large, 65,800 ft2 (6,113 m2) facility functions as the Group’s central genomics laboratory in North ...
read more
Thursday, November 17, 2016
Eurofins Genomics has announced the launch of a limited beta program for its new DNA synthesis service for scientists who need small quantities of very high-quality starting material for routine molecular and synthetic biology applications. The ...
read more
Monday, December 12, 2016
Eurofins Genomics has announced the U.S. launch of its EXTREmer oligonucleotides, extremely long oligos that are developed using high-fidelity synthesis chemistry on the company's new DNA synthesis platform. Designed for synthetic biology, next-...
read more
Eurofins Genomics has announced the expansion of its Express Oligo service, which will allow more customers to receive their primers in a shorter turnaround time, without the usual price premium or compromise in quality found with other providers. ...
read more